Zenotech Laboratories

Zenotech Laboratories Operating Expenses

The Total Operating Expenses of Zenotech Laboratories (532039.BO) as of Nov 22, 2026 is 14.13 M INR. In the previous year, Total Operating Expenses was 205.90 M INR — a change of -93.14% (lower).

Operating Expenses

14.13 MINR

YoY

-93.14%

Last updated:

Total Operating Expenses of Zenotech Laboratories is 2026 14.13 M INR. Total Operating Expenses of Zenotech Laboratories was 2025 205.90 M INR. It decreases by -93.14% lower compared to the previous year.

The Zenotech Laboratories Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2019
139.87 M INR
Jan 1, 2020
141.36 M INR
Jan 1, 2021
135.41 M INR
Jan 1, 2022
164.05 M INR
Jan 1, 2023
141.72 M INR
Jan 1, 2024
164.39 M INR
Jan 1, 2025
205.90 M INR
Jan 1, 2026
14.13 M INR
The Zenotech Laboratories Operating Expenses history
YEAROperating ExpensesYoY
14.13 MINR-93.14%
205.90 MINR+25.25%
164.39 MINR+15.99%
141.72 MINR-13.61%
164.05 MINR+21.15%
135.41 MINR-4.21%
141.36 MINR+1.06%
139.87 MINR-15.41%
165.36 MINR+447.43%
30.21 MINR+34.12%
22.52 MINR-31.44%
32.85 MINR-57.39%
77.10 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zenotech Laboratories Stock analysis

What does Zenotech Laboratories do? Zenotech Laboratories Ltd manufactures and markets pharmaceutical products, specializing in oncology, biotechnology, and general injectables. The company operates from a manufacturing facility in Turkapally village, Shamirpet Mandal, Telangana, producing specialty generic injectables for the pharmaceutical sector. Its products are sold to healthcare providers and distributors within the pharmaceutical industry, targeting markets that require specialized injectable solutions. The firm's business model focuses on the production and distribution of generic injectables, leveraging its facility in Telangana to serve both domestic and international markets. By concentrating on oncology and biotechnology injectables, Zenotech addresses specific medical needs, generating revenue through the sale of these high-demand pharmaceutical products to hospitals, clinics, and pharmaceutical distributors. Zenotech Laboratories Ltd's revenue streams come from the sale of its specialty generic injectables, including oncology and biotechnology products, to healthcare institutions and distribution networks. The company's manufacturing capabilities in Telangana support its role as a supplier in the pharmaceutical supply chain, with a focus on injectable formulations that cater to critical healthcare applications. Zenotech Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zenotech Laboratories stock

Total Operating Expenses of Zenotech Laboratories is 14.13 M INR in 2026.

Total Operating Expenses of Zenotech Laboratories changed from 205.90 M INR to 14.13 M INR, representing a -93.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Zenotech Laboratories since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Zenotech Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Zenotech Laboratories

All Key Metrics — Zenotech Laboratories